Latest Breaking News On - Melissa ullerich - Page 3 : vimarsana.com

SAB Biotherapeutics Announces Publication of Preclinical Data Demonstrating SAB-185 Effectively Neutralizes SARS-CoV-2 Variants

SAB Biotherapeutics Announces Publication of Preclinical Data Demonstrating SAB-185 Effectively Neutralizes SARS-CoV-2 Variants

SAB Biotherapeutics Strengthens Senior Management Team with Appointment of Kipp Erickson, PhD as Chief Operating Officer

SAB Biotherapeutics Strengthens Senior Management Team with Appointment of Kipp Erickson, PhD as Chi

SAB Biotherapeutics Announces New Appointments to its Board of Directors

Press release content from Business Wire. The AP news staff was not involved in its creation. SAB Biotherapeutics Announces New Appointments to its Board of Directors December 16, 2020 GMT SIOUX FALLS, S.D. (BUSINESS WIRE) Dec 16, 2020 SAB Biotherapeutics (SAB), a clinical-stage biopharmaceutical company developing a novel immunotherapy platform to produce specifically targeted, high potency, fully human polyclonal antibodies without the need for human serum, today announced the appointment of Mani Mohindru, PhD, and Mervyn Turner, PhD to its Board of Directors. “We are excited to welcome Drs. Mohindru and Turner to our Board of Directors. Each industry executive brings a wealth of corporate strategy, drug development and financial expertise,” said Eddie J. Sullivan, PhD, co-founder, president and CEO of SAB Biotherapeutics. “Both Drs. Mohindru and Turner are joining SAB at a pivotal time as we continue to advance a new class of immunotherapies that leverage the native hu